Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
24 hedge funds and large institutions have $6.31M invested in Intellipharmaceuticals International Inc. in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 6 closing their positions.
100% more capital invested
Capital invested by funds: $3.16M → $6.31M (+$3.15M)
14% less funds holding
Funds holding: 28 → 24 (-4)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
65% less call options, than puts
Call options by funds: $6K | Put options by funds: $17K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$4.82M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$1.54M |
| 3 |
VF
Virtu Financial
New York
|
+$24.6K |
| 4 |
Barclays
London,
United Kingdom
|
+$9.03K |
| 5 |
FMA
FNY Managed Accounts
New York
|
+$1.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$867K |
| 2 |
FFA
First Foundation Advisors
Irvine,
California
|
-$346K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$37K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$8.14K |
| 5 |
Morgan Stanley
New York
|
-$7.56K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$108 | +15 | +75% |
|
IPCI Hedge Fund Activity: Q1 2018 in Review
24 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q1 2018, worth a combined $6.31M — up 100% from $3.16M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IPCI and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was Armistice Capital, adding an estimated $4.82M. The largest seller was Sabby Management, exiting entirely with an estimated $867K sold.
- 24 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q1 2018, down from 28 in Q4 2017.
- Funds reported $6.31M of Intellipharmaceuticals International Inc. stock for Q1 2018, up 100% quarter-over-quarter.
- 3 funds opened new Intellipharmaceuticals International Inc. positions in Q1 2018 and 6 closed out, a net change of -3 holders.
- The largest Intellipharmaceuticals International Inc. buyer in Q1 2018 was Armistice Capital, an estimated $4.82M added.
- The largest Intellipharmaceuticals International Inc. seller in Q1 2018 was Sabby Management, an estimated $867K sold.
Based on aggregated 13F filings for Q1 2018.